1-TERT-BUTYL 2-METHYL (2R,4S)-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE, 95.0%, 10g

TERT-BUTYL N-(3-FLUOROPIPERIDIN-4-YL)-N-METHYLCARBAMATE, 95.0%, 250mg

2,4(1H,3H)-QUINAZOLINEDIONE, 3-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-8-METHYL-, 98.0%, 250mg

(S)-2-Methylmorpholine hydrochloride, 95.0%, 10g

(5-FLUORO-6-METHYL-3-PYRIDYL)BORONIC ACID, 95%, 5g

BENZYL 1-BENZYL-4-METHYLPIPERAZINE-2-CARBOXYLATE, 95.0%, 250mg

1,3-Cyclohexanedione, 99.00%, 100g

o-Anisidine-5-sulfonic Acid>95.0%(T)25g

(S)-beta-(4-Chlorophenyl)alaninol, 97.0%, 250mg

3-Benzyl-6-bromo-2-chloroquinoline, 95.0%, 100g

5-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid, 95.0%, 100mg

1H,1H,2H,2H-Tridecafluoro-n-octyl Iodide>97.0%(GC)25g

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm